Authors: Dr. Neha Joshi, Mr. Aditya Singh
ABSTRACT: Global pharmacovigilance databases, including VigiBase, FAERS, and EudraVigilance, play a crucial role in monitoring drug safety across populations. These repositories collect and analyze adverse drug reactions (ADRs) reported by healthcare professionals, patients, and manufacturers. This paper discusses the structure, functionalities, and impact of these databases on drug safety surveillance, signal detection, and regulatory decision-making. It also highlights the challenges, such as data standardization, underreporting, and integration with national pharmacovigilance systems. Tables summarizing database characteristics and reporting metrics are included. Effective utilization of global pharmacovigilance databases enhances patient safety, informs regulatory actions, and supports the rational use of medicines worldwide.*
KEYWORDS: Pharmacovigilance, VigiBase, FAERS, EudraVigilance, Adverse Drug Reactions, Drug Safety, Signal Detection
Full Issue
| View or download the full issue | PDF 17-22 |